[go: up one dir, main page]

BR9708614A - Derivado de ácido carboxílico e utilização de um composto e de uma combinação de um composto - Google Patents

Derivado de ácido carboxílico e utilização de um composto e de uma combinação de um composto

Info

Publication number
BR9708614A
BR9708614A BR9708614A BR9708614A BR9708614A BR 9708614 A BR9708614 A BR 9708614A BR 9708614 A BR9708614 A BR 9708614A BR 9708614 A BR9708614 A BR 9708614A BR 9708614 A BR9708614 A BR 9708614A
Authority
BR
Brazil
Prior art keywords
compound
combination
carboxylic acid
acid derivative
derivative
Prior art date
Application number
BR9708614A
Other languages
English (en)
Inventor
Wilhelm Amberg
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of BR9708614A publication Critical patent/BR9708614A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • C07D215/227Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/34One oxygen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60Three or more oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Quinoline Compounds (AREA)
BR9708614A 1996-04-12 1997-04-04 Derivado de ácido carboxílico e utilização de um composto e de uma combinação de um composto BR9708614A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19614542A DE19614542A1 (de) 1996-04-12 1996-04-12 Neue Carbonsäurederivate, ihre Herstellung und Verwendung
PCT/EP1997/001687 WO1997038982A1 (de) 1996-04-12 1997-04-04 Neue carbonsäurederivate, ihre herstellung und verwendung

Publications (1)

Publication Number Publication Date
BR9708614A true BR9708614A (pt) 1999-08-03

Family

ID=7791123

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9708614A BR9708614A (pt) 1996-04-12 1997-04-04 Derivado de ácido carboxílico e utilização de um composto e de uma combinação de um composto

Country Status (23)

Country Link
US (1) US6103732A (pt)
EP (1) EP0892788A1 (pt)
JP (1) JP2000508325A (pt)
KR (1) KR20000005366A (pt)
CN (1) CN1216042A (pt)
AR (1) AR006593A1 (pt)
AU (1) AU711293B2 (pt)
BG (1) BG63202B1 (pt)
BR (1) BR9708614A (pt)
CA (1) CA2250764A1 (pt)
CO (1) CO4900038A1 (pt)
DE (1) DE19614542A1 (pt)
HR (1) HRP970200A2 (pt)
ID (1) ID19050A (pt)
IL (1) IL126026A0 (pt)
NO (1) NO311802B1 (pt)
NZ (1) NZ331704A (pt)
PL (1) PL329240A1 (pt)
SK (1) SK127698A3 (pt)
TR (1) TR199802042T2 (pt)
TW (1) TW419465B (pt)
WO (1) WO1997038982A1 (pt)
ZA (1) ZA973096B (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU740351B2 (en) * 1996-12-18 2001-11-01 Abbott Gmbh & Co. Kg Heterocyclic carboxylic acid derivatives, their preparation ans use as endothelin receptor antagonists
US6030975A (en) * 1997-03-14 2000-02-29 Basf Aktiengesellschaft Carboxylic acid derivatives, their preparation and use in treating cancer
HUP0004935A3 (en) * 1997-09-04 2001-12-28 Basf Ag Novel carboxylic acid derivatives, their production and their use as mixed eta/etb endothelin-receptor antagonists
HU0900792D0 (en) * 1997-10-17 2010-03-01 Ark Therapeutics Ltd Use of renin-angiotensin inhibitors
US7566452B1 (en) 1999-05-04 2009-07-28 New York University Cancer treatment with endothelin receptor antagonists
PT1243262E (pt) * 2001-03-20 2006-10-31 Sanol Arznei Schwarz Gmbh Nova utilizacao de uma classe de compostos peptideos para o tratamento da dor inflamatoria nao neuropatica
ES2185606T3 (es) * 2001-03-21 2003-05-01 Sanol Arznei Schwarz Gmbh Nuevo uso de una clase de compuestos peptidicos para tratamiento de la alodinia u otros tipos diferentes de dolor cronico o fantasma.
CN1950101B (zh) 2004-04-16 2011-03-30 舒沃茨药物股份公司 肽化合物用于预防和治疗慢性头痛的用途
EP1781276B1 (en) * 2004-08-27 2010-06-23 UCB Pharma GmbH Use of peptide compounds for treating bone cancer pain, chemotherapy- and nucleoside-induced pain
US20070043120A1 (en) * 2005-08-18 2007-02-22 Bettina Beyreuther Therapeutic combination for painful medical conditions
EP1754476A1 (en) * 2005-08-18 2007-02-21 Schwarz Pharma Ag Lacosamide (SPM 927) for treating myalgia, e.g. fibromyalgia
US20070048372A1 (en) * 2005-08-18 2007-03-01 Srz Properties, Inc. Method for treating non-inflammatory osteoarthritic pain
PT2462990E (pt) 2006-06-15 2014-04-02 Ucb Pharma Gmbh Composição farmacêutica com efeito anticonvulsivo sinergístico

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4411225A1 (de) * 1994-03-31 1995-10-05 Basf Ag Verwendung von Carbonsäurederivaten als Arzneimittel
WO1996000219A1 (en) * 1994-06-27 1996-01-04 Ciba-Geigy Ag Pyrimidinyl- and triazinyl-oxy and thio-3-haloalkyl-propionic acid derivatives as herbicides

Also Published As

Publication number Publication date
BG102770A (en) 1999-11-30
ID19050A (id) 1998-06-04
AR006593A1 (es) 1999-09-08
IL126026A0 (en) 1999-05-09
CO4900038A1 (es) 2000-03-27
NO311802B1 (no) 2002-01-28
KR20000005366A (ko) 2000-01-25
NO984713L (no) 1998-10-09
US6103732A (en) 2000-08-15
ZA973096B (en) 1998-10-12
BG63202B1 (bg) 2001-06-29
TW419465B (en) 2001-01-21
NO984713D0 (no) 1998-10-09
PL329240A1 (en) 1999-03-15
EP0892788A1 (de) 1999-01-27
TR199802042T2 (xx) 2000-09-21
AU711293B2 (en) 1999-10-07
WO1997038982A1 (de) 1997-10-23
AU2636497A (en) 1997-11-07
HRP970200A2 (en) 1998-04-30
JP2000508325A (ja) 2000-07-04
CN1216042A (zh) 1999-05-05
NZ331704A (en) 2000-06-23
DE19614542A1 (de) 1997-10-16
CA2250764A1 (en) 1997-10-23
SK127698A3 (en) 2000-03-13

Similar Documents

Publication Publication Date Title
BR9510256A (pt) Derivados de ácido 3-aril-tetrônico
FI971991A7 (fi) 2-syaaniakryylihappoesterit
DE69813570D1 (de) 5-alkyl-2-arylaminophenylessigsäure und derivative
NO924978L (no) Chinolon- og naftyridon-karboksylsyrederivater
DE69703385D1 (de) Alkoxyessigsäure-derivate
NO990821D0 (no) Arylsulfonylamino-hydroksaminsyre-derivater
PT874558E (pt) Composicoes liquidas orais compreendendo um composto de calcio e um acidulante
EE9900069A (et) Propioonhappe derivaadid ja nende kasutamine
FI945688A7 (fi) Etikkahappojohdannaisia
NO2011015I1 (no) Pallperidon palmitatester
FI950910L (fi) Rasvahappojohdannaiset
HUP0105027A3 (en) Carboxylic acids and carboxylic acid isosteres of n-heterocyclic compounds and their use
DE59700915D1 (de) Stabilisierter Milchsäurementhylester
PT868183E (pt) Formulacoes injectaveis de quinolona
NO994595L (no) Salt av naftyridin-karboksylsyrederivat
BR9708614A (pt) Derivado de ácido carboxílico e utilização de um composto e de uma combinação de um composto
FI954007A0 (fi) Substituoitujen 4-fenyyli-6-amino-nikotiinihappojohdannaisten käyttö lääkeaineena
FI950909L (fi) Rasvahappojohdannaisia
BR9708609A (pt) Derivado de ácido carboxilico e usos de compostos e de uma combinação de composto
FI944045L (fi) Aromaattisia karboksyylihappojohdannaisia
DE59305938D1 (de) Pyridyloxy-acrylsäureester
DE69718338D1 (de) 3-alkoxyisoxazol-4-yl-substituierte 2-aminocarbonsäurederivate
DE59712000D1 (de) Herstellung von Carbonsäurefluoriden
PL335601A1 (en) Derivatives of 2-substituted benzoylcycloalkyl carboxylic acid
FI970195A7 (fi) Trifluormetyylikinoliinikarboksyylihappojohdannainen

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B25A Requested transfer of rights approved

Owner name: ABBOTT GMBH AND CO. KG (DE)

Free format text: TRANSFERIDO DE: BASF AKTIENGESELLSCHAFT

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: NAO APRESENTADA A GUIA DE CUMPRIMENTO DE EXIGENCIA. REFERENTE AS 7A E 8A ANUIDADES.